Inventor · disambiguated record
Baihua Hu
Also filed as: HU BAIHUA
32 granted patents·15 pending applications·354 citations·filing 1998–2019
97Inventor score
Top patents by PatentIndex Score
47 records- 0198US7285682B2Terphenyl guanidines as β-secretase inhibitorsWYETH CORP·Filed 2006·Granted Oct 23, 2007·39 cites·20 claims
- 0295US6797708B2Inhibitors of cytosolic phospholipase A2WYETH CORP·Filed 2002·Granted Sep 28, 2004·66 cites·47 claims
- 0391US6984735B2Process for making an aldehydeWYETH CORP·Filed 2003·Granted Jan 10, 2006·33 cites·14 claims
- 0490US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0589US6635771B2N-benzhydryl indole compoundsWYETH CORP·Filed 2002·Granted Oct 21, 2003·29 cites·8 claims
- 0688US9605005B2Alkynyl alcohols and methods of useGENENTECH INC·Filed 2016·Granted Mar 28, 2017·5 cites·4 claims
- 0786US7605156B2Methods for the use of inhibitors of cytosolic phospholipase A2WYETH CORP·Filed 2005·Granted Oct 20, 2009·10 cites·34 claims
- 0885US6410734B12-substituted thiazolidinones as beta-3 adrenergic receptor agonistsWYETH CORP·Filed 2001·Granted Jun 25, 2002·13 cites·4 claims
- 0984US10179782B2Substituted sulfonamide compoundsGENENTECH INC·Filed 2016·Granted Jan 15, 2019·5 cites·10 claims
- 1084US6525202B2Cyclic amine phenyl beta-3 adrenergic receptor agonistsWYETH CORP·Filed 2001·Granted Feb 25, 2003·17 cites·3 claims
- 1182US7576215B2Quinolines and pharmaceutical compositions thereofWYETH CORP·Filed 2004·Granted Aug 18, 2009·21 cites·9 claims
- 1282US7101875B2Methods for treating arthritic disordersWYETH CORP·Filed 2002·Granted Sep 5, 2006·13 cites·48 claims
- 1382US7022716B2Cyclic amine phenyl beta-3 adrenergic receptor agonistsWYETH CORP·Filed 2002·Granted Apr 4, 2006·14 cites·9 claims
- 1481US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 1579US6821991B22-substituted thiazolidinones as β-3 adrenergic receptor agonistsWYETH CORP·Filed 2003·Granted Nov 23, 2004·7 cites·5 claims
- 1678US6498170B2Cyclamine sulfonamides as β-3 adrenergic receptor agonistsWYETH CORP·Filed 2001·Granted Dec 24, 2002·7 cites·9 claims
- 1775US7906548B2Methods for the use of inhibitors of cytosolic phospholipase A2WYETH LLC·Filed 2009·Granted Mar 15, 2011·2 cites·22 claims
- 1875US7268159B2Substituted indolesWYETH CORP·Filed 2004·Granted Sep 11, 2007·9 cites·23 claims
- 1975US7265148B2Substituted pyrrole-indolesWYETH CORP·Filed 2004·Granted Sep 4, 2007·6 cites·27 claims
- 2075US6583140B22-substituted thiazolidinones as beta-3 adrenergic receptor agonistsWYETH CORP·Filed 2002·Granted Jun 24, 2003·5 cites·12 claims
- 2172US11236046B2Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulatorsGENENTECH INC·Filed 2019·Granted Feb 1, 2022·0 cites·1 claims
- 2272US6172057B1N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 1998·Granted Jan 9, 2001·36 cites·23 claims
- 2370US7713964B2Methods for treating asthmatic conditionsWYETH LLC·Filed 2002·Granted May 11, 2010·5 cites·48 claims
- 2470US7442805B2Substituted sulfonamide-indolesWYETH CORP·Filed 2004·Granted Oct 28, 2008·3 cites·11 claims
- 2566US7332521B2Substituted indolesWYETH CORP·Filed 2004·Granted Feb 19, 2008·2 cites·25 claims
- 2663US8951993B2Phosphorus containing compounds as protein kinase inhibitorsHU BAIHUA·Filed 2012·Granted Feb 10, 2015·1 cites·33 claims
- 2759US2018282272A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2018·Application pending·0 cites
- 2859US2008319046A1Substituted sulfonamide-indolesWYETH CORP·Filed 2008·Application pending·0 cites
- 2958US2016096850A9Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 3058US2015057260A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 3157US2018118680A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2017·Application pending·0 cites
- 3256US2007299126A1Substituted pyrrole-indolesWYETH CORP·Filed 2007·Application pending·0 cites
- 3355US7683091B2Substituted indoles and methods of their useWYETH CORP·Filed 2006·Granted Mar 23, 2010·0 cites·6 claims
- 3453US2010120778A1Quinoxaline-based lxr modulatorsWYETH CORP·Filed 2009·Application pending·0 cites
- 3553US2007299125A1Substituted indolesWYETH CORP·Filed 2007·Application pending·0 cites
- 3653US2016221945A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2016·Application pending·0 cites
- 3752US10913742B2Oxadiazolones as transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Feb 9, 2021·0 cites·13 claims
- 3852US2017210724A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 3952US2017145034A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 4052US2010184786A1Polar QuinazolinesWYETH LLC·Filed 2009·Application pending·0 cites
- 4151US10766878B2Sulfonylcycloalkyl carboxamide compoundsGENENTECH INC·Filed 2019·Granted Sep 8, 2020·0 cites·23 claims
- 4250US10695348B2Sulfonyl pyridyl TRP inhibitorsGENENTECH INC·Filed 2019·Granted Jun 30, 2020·0 cites·10 claims
- 4349US2016185797A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2016·Application pending·0 cites
- 4448US2009069373A1Quinoline AcidsWYETH CORP·Filed 2008·Application pending·0 cites
- 4545US7423044B2Pyrimidine derivatives useful in the treatment of insulin resistance and hyperglycemiaWYETH CORP·Filed 2003·Granted Sep 9, 2008·0 cites·23 claims
- 4644US7700595B2Cinnoline compoundsWYETH LLC·Filed 2006·Granted Apr 20, 2010·0 cites·45 claims
- 4741US2010137363A1Substituted Indoles And Methods Of Their UseWYETH LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Baihua Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →